These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 34684749)

  • 1. Shedding Light on the Pharmacological Interactions between μ-Opioid Analgesics and Angiotensin Receptor Modulators: A New Option for Treating Chronic Pain.
    Király K; Karádi DÁ; Zádor F; Mohammadzadeh A; Galambos AR; Balogh M; Riba P; Tábi T; Zádori ZS; Szökő É; Fürst S; Al-Khrasani M
    Molecules; 2021 Oct; 26(20):. PubMed ID: 34684749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripherally acting opioid analgesics and peripherally-induced analgesia.
    Martínez V; Abalo R
    Behav Pharmacol; 2020 Apr; 31(2&3):136-158. PubMed ID: 32168025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential for Kappa-Opioid Receptor Agonists to Engineer Nonaddictive Analgesics: A Narrative Review.
    Kaski SW; White AN; Gross JD; Siderovski DP
    Anesth Analg; 2021 Feb; 132(2):406-419. PubMed ID: 33332902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why mu-opioid agonists have less analgesic efficacy in neuropathic pain?
    Martínez-Navarro M; Maldonado R; Baños JE
    Eur J Pain; 2019 Mar; 23(3):435-454. PubMed ID: 30318675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Mu-Delta Opioid Agonist Demonstrates Enhanced Efficacy With Reduced Tolerance and Dependence in Mouse Neuropathic Pain Models.
    Lei W; Vekariya RH; Ananthan S; Streicher JM
    J Pain; 2020; 21(1-2):146-160. PubMed ID: 31201990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replacement of current opioid drugs focusing on MOR-related strategies.
    Busserolles J; Lolignier S; Kerckhove N; Bertin C; Authier N; Eschalier A
    Pharmacol Ther; 2020 Jun; 210():107519. PubMed ID: 32165137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analgesic Properties of Opioid/NK1 Multitarget Ligands with Distinct in Vitro Profiles in Naive and Chronic Constriction Injury Mice.
    Starnowska J; Costante R; Guillemyn K; Popiolek-Barczyk K; Chung NN; Lemieux C; Keresztes A; Van Duppen J; Mollica A; Streicher J; Vanden Broeck J; Schiller PW; Tourwé D; Mika J; Ballet S; Przewlocka B
    ACS Chem Neurosci; 2017 Oct; 8(10):2315-2324. PubMed ID: 28699350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D2-like receptor agonist synergizes the μ-opioid agonist spinal antinociception in nociceptive, inflammatory and neuropathic models of pain in the rat.
    Mercado-Reyes J; Almanza A; Segura-Chama P; Pellicer F; Mercado F
    Eur J Pharmacol; 2019 Jun; 853():56-64. PubMed ID: 30876975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agonist-dependent attenuation of mu-opioid receptor-mediated G-protein activation in the dorsal root ganglia of neuropathic rats.
    Obara I; Gunduz Cinar O; Starowicz K; Benyhe S; Borsodi A; Przewlocka B
    J Neural Transm (Vienna); 2010 Apr; 117(4):421-9. PubMed ID: 20213428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bifunctional μ opioid and σ
    Zhuang T; Xiong J; Hao S; Du W; Liu Z; Liu B; Zhang G; Chen Y
    Eur J Med Chem; 2021 Nov; 223():113658. PubMed ID: 34175542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Quest for More Effective Analgesics with Reduced Abuse Liability and Fewer Adverse Effects: Promises, Pitfalls, and Future Perspectives of Biased Agonists at Opioid Receptors.
    Bedini A
    Methods Mol Biol; 2021; 2201():181-192. PubMed ID: 32975799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biased Opioid Antagonists as Modulators of Opioid Dependence: Opportunities to Improve Pain Therapy and Opioid Use Management.
    Sadee W; Oberdick J; Wang Z
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32932935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biased Opioid Ligands.
    Faouzi A; Varga BR; Majumdar S
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32948048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive allosteric modulation of the mu-opioid receptor produces analgesia with reduced side effects.
    Kandasamy R; Hillhouse TM; Livingston KE; Kochan KE; Meurice C; Eans SO; Li MH; White AD; Roques BP; McLaughlin JP; Ingram SL; Burford NT; Alt A; Traynor JR
    Proc Natl Acad Sci U S A; 2021 Apr; 118(16):. PubMed ID: 33846240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The amino-terminal heptapeptide of the algesic substance P provides analgesic effect in relieving chronic neuropathic pain.
    Nyman J; Guo N; Sandström A; Hallberg M; Nyberg F; Yu L
    Eur J Pharmacol; 2021 Feb; 892():173820. PubMed ID: 33345847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic attenuation of chronic pain using mu opioid and cannabinoid receptor 2 agonists.
    Grenald SA; Young MA; Wang Y; Ossipov MH; Ibrahim MM; Largent-Milnes TM; Vanderah TW
    Neuropharmacology; 2017 Apr; 116():59-70. PubMed ID: 28007501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. μ-Opioid receptors in primary sensory neurons are essential for opioid analgesic effect on acute and inflammatory pain and opioid-induced hyperalgesia.
    Sun J; Chen SR; Chen H; Pan HL
    J Physiol; 2019 Mar; 597(6):1661-1675. PubMed ID: 30578671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innovative Opioid Peptides and Biased Agonism: Novel Avenues for More Effective and Safer Analgesics to Treat Chronic Pain.
    Bedini A; Spampinato S
    Curr Med Chem; 2018; 25(32):3895-3916. PubMed ID: 28215164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel fentanyl-based dual μ/δ-opioid agonists for the treatment of acute and chronic pain.
    Podolsky AT; Sandweiss A; Hu J; Bilsky EJ; Cain JP; Kumirov VK; Lee YS; Hruby VJ; Vardanyan RS; Vanderah TW
    Life Sci; 2013 Dec; 93(25-26):1010-6. PubMed ID: 24084045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The multifunctional peptide DN-9 produced peripherally acting antinociception in inflammatory and neuropathic pain via μ- and κ-opioid receptors.
    Xu B; Zhang M; Shi X; Zhang R; Chen D; Chen Y; Wang Z; Qiu Y; Zhang T; Xu K; Zhang X; Liedtke W; Wang R; Fang Q
    Br J Pharmacol; 2020 Jan; 177(1):93-109. PubMed ID: 31444977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.